Skip to content

Esflurbiprofen

MUSCULO-SKELETAL SYSTEM

Also known as: loqoa, TT-063

PMDA approvedATC M02AA29

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Esflurbiprofen is a drug catalogued in DrugCentral. It was first approved by the PMDA in 2015. DrugCentral lists 2 molecular targets, including Ptgs1 and PTGS2. Recorded indications include Osteoarthritis.

  • Molecular targets: Ptgs1 and PTGS2 (2 listed in DrugCentral).
  • Indications: Osteoarthritis.
  • ATC code: M02AA29 (Antiinflammatory preparations, non-steroids for topical use).
  • Molecular formula: C15H13FO2; molecular weight 244.26 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Osteoarthritis

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Prostaglandin G/H synthase 1Ptgs1unknownIC50 7.52
Prostaglandin G/H synthase 2PTGS2unknownIC50 6.04

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
2015-09-28PMDA—Taisho Pharmaceutical Co., Ltd.

ATC classification

ATC codeTherapeutic hierarchy
M02AA29MUSCULO-SKELETAL SYSTEM › TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN › TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN › Antiinflammatory preparations, non-steroids for topical use

Chemical structure

Molecular formulaC15H13FO2
Molecular weight244.26 g/mol
CAS number51543-39-6
InChIKeySYTBZMRGLBWNTM-JTQLQIEISA-N
PubChem CID72099
C[C@H](C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Esflurbiprofen used for?

DrugCentral lists the following indications for Esflurbiprofen: Osteoarthritis.

How does Esflurbiprofen work?

Its molecular targets in DrugCentral include Ptgs1 and PTGS2.

When was Esflurbiprofen first approved?

Esflurbiprofen was first approved by the PMDA in 2015.

What is the chemical formula of Esflurbiprofen?

Esflurbiprofen has the molecular formula C15H13FO2 and a molecular weight of 244.26 g/mol.

Browse: all drugs starting with E · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval2015-09-28
AgencyPMDA
Targets2
Indications1
FormulaC15H13FO2
DrugCentral ID5060
Interactive profile